Al Riyami Mohamed S, Al Saidi Sulaiman, Al Ghaithi Badria, Al Maskari Anisa, Lala Sadiq, Mohsin Nabil, Hirshikesan Lekha, Al Kalbani Naifain
Pediatric Nephrology Unit, Department of Child Health, Royal Hospital, Muscat, Oman.
Urology Unit, Department of Surgery, Royal Hospital, Muscat, Oman.
Oman Med J. 2018 Jan;33(1):7-14. doi: 10.5001/omj.2018.03.
This study sought to report 22 years experience in pediatric kidney transplantation in Oman.
Electronic charts of all Omani children below 13 years of age who received a kidney transplant from January 1994 to December 2015 were reviewed. Data collected included patient demographics, etiology of end-stage kidney disease, modality and duration of dialysis, donor type, complication of kidney transplantation (including surgical complications, infections, graft rejection) graft and patient survival, and duration of follow-up.
During the study period transplantation from 27 living related donors (LRDs), 42 living unrelated donors (LURDs), also referred to as commercial transplant, and one deceased donor were performed. The median age at transplantation was nine years for both groups. The most common primary diagnosis was congenital anomalies of the kidney and urinary tract in 32.8% of patients followed by familial nephrotic syndrome in 20.0% and polycystic kidney disease in 18.5%. Almost half the patients were on hemodialysis before transplantation, 35.7% were on peritoneal dialysis, and 14.2% received preemptive renal transplantation. Children who received LURD kidneys had high surgical complications (42.8%) compared to the LRDs group (17.8%). Five patients from LURDs group had early graft nephrectomy and four patients developed non-graft function or delayed graft function. In addition, patients in the LURDs group had a higher incidence of hypertension and acute rejection. Graft and patient survival were both better in the LRDs than the LURDs group.
Although our pediatric kidney transplant program is a young program it has had successful patient outcomes comparable to international programs. Our study provides evidence that in addition to legal and ethical issues with commercial transplant, it also carries significantly higher morbidity and reduced graft and patient survival.
本研究旨在报告阿曼小儿肾移植22年的经验。
回顾了1994年1月至2015年12月期间接受肾移植的所有13岁以下阿曼儿童的电子病历。收集的数据包括患者人口统计学资料、终末期肾病的病因、透析方式和时间、供体类型、肾移植并发症(包括手术并发症、感染、移植物排斥反应)、移植物和患者存活率以及随访时间。
在研究期间,进行了27例亲属活体供肾(LRD)移植、42例非亲属活体供肾(LURD,也称为商业移植)移植和1例尸体供肾移植。两组患者移植时的中位年龄均为9岁。最常见的主要诊断是32.8%的患者为先天性肾脏和尿路异常,其次是20.0%的患者为家族性肾病综合征,18.5%的患者为多囊肾病。几乎一半的患者在移植前接受血液透析,35.7%接受腹膜透析,14.2%接受了先发制人的肾移植。与LRD组(17.8%)相比,接受LURD肾移植的儿童手术并发症发生率较高(42.8%)。LURD组有5例患者早期进行了移植肾切除术,4例患者出现移植肾功能不良或移植肾功能延迟。此外,LURD组患者高血压和急性排斥反应的发生率较高。LRD组的移植物和患者存活率均高于LURD组。
尽管我们的小儿肾移植项目开展时间不长,但患者的成功治疗结果与国际项目相当。我们的研究表明,除了商业移植存在的法律和伦理问题外,它还具有明显更高的发病率以及更低的移植物和患者存活率。